Cancer Therapy: Monoclonal Antibodies, Lymphokines. New Developments in Surgical Oncology and Chemo- And Hormonal Therapy

Front Cover
Springer-Verlag, 1989 - Medical - 308 pages
0 Reviews
A variety of new cancer therapy modalities are discussed and evaluated in this book. It aims to demonstrate that the combination of classical chemo- and radiotherapy with new approaches in the field of immunotherapy can result in an improved treatment modality. Immunotherapy in this context consists of therapy with monoclonal antibodies, hematopoietic growth factors and other lymphokines. Results of early clinical trials with IL-2, GM-CSF and monoclonal antibodies against gastrointestinal tumors and melanoma are included. The progress in regional chemotherapy strategies, for example of the liver, is shown. In addition, the development of new chemotherapeutic agents with a different mode of action as well as better tolerability is presented. The use of hormones, such as LH-RH agonists, allows hormone-dependent tumors such as prostatic and breast cancer to be treated without strong adverse reactions. These recent findings give the reader insight into exciting therapeutic directions made possible by such combined, rather than single, modalities.

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

R A REISFELD B MULLER and H M YANG
3
H KALOFONOS and A A EPENETOS
18
BUCHLER R KOBEL R KLAPDOR K H MUHRER
32
Copyright

16 other sections not shown

Other editions - View all

Common terms and phrases

Bibliographic information